abstract |
A macrophage or monocyte for use in treating a subject with cancer, wherein the macrophage or monocyte is induced ex vivo to express an elevated level of endogenous Hom-1, or wherein the macrophage or monocyte is genetically modified to express an elevated level elevated Hom-1, to present antitumor activity. |